Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke be Extended to 4.5 Hours?

Authors

  • Tejal Patel Family Health Team
  • Peter S Loewen Vancouver Coastal Health – Providence Health Care, University of British Columbia

DOI:

https://doi.org/10.4212/cjhp.v62i3.798

Downloads

Download data is not yet available.

Downloads

Issue

Vol. 62 No. 3 (2009)

Section

Point Counterpoint / Le pour et le contre

License

Copyright © Canadian Society of Healthcare-Systems Pharmacy.

After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP (publications@cshp.ca) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors. Please note that any forms (e.g., preprinted orders and patient intake forms) used by a specific hospital or other health care facility and included as illustrative material with a manuscript are exempt from this copyright transfer. The CJHP will require a letter from the hospital or health care facility granting permission to publish the document(s).